Electrophoresis reagents are basically gel & buffers, generally used for electrophoretic-separation of the biological molecules. Electrophoresis is a special type of technique in which macromolecules like RNA, DNA, and proteins are detected or separated based on their size & charge. This technique is broadly used in research & development (R&D) activities in the fields of genomics, academic institutes, proteomics, clinical research, and diagnostic laboratories. Growing use of electrophoresis reagents in the preclinical research and drug discovery is fueling the demand of global market. Governments of emerging economies are mounting their investments in R&D to reinforce their healthcare industry. Key factors like increase in per capita income and growth in healthcare expenditure are expected to drive the growth of market in the forecast period.
As per analysis, Global Electrophoresis Reagents Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027. Some of the key companies operating in the global electrophoresis reagents market include Merck Millipore, Agilent Technologies, Inc., Thermo Fisher Scientific, GE Healthcare, SERVA Electrophoresis, Lonza Group, AG, PerkinElmer, Bio-Rad Laboratories, Inc., Qiagen N.V and among others. Leading industry players are implementing a range of strategies to fortify their footprints in the global & regional markets. These strategies generally include mergers & acquisitions, collaborations for reagent development, partnerships, and joint ventures.
Based on types, electrophoresis reagents market can be segregated as capillary electrophoresis and gel electrophoresis. The gel electrophoresis segment dominates the global market owing to increase in burden of infectious diseases, cancer, and genetic disorders coupled with growth in applications in the pharmaceutical & biotechnology industries. In addition, based on application, market can be segregated as DNA & RNA analysis and protein analysis. Protein analysis segment is expected to witness higher growth rate caused by growth in focus on proteomics research by pharmaceutical & biotechnology companies during the forecast period.
Growth in number of industry–academic research collaborations, followed by rise in incidences of cancer, infectious diseases, and genetic disorders, rapidly increasing geriatric population, increase in funding for genomic & proteomic research and growth in technological advancements are some major factors, which are responsible for growth of the electrophoresis reagents market. Apart from this, presence of alternative technologies offering better efficiency & results and time-consuming operations & limited sample analysis through gel electrophoresis may impact the market. Moreover, rise in demand for personalized medicine, rapid growth in emerging countries and rise in shift from plant-derived to genome-based drug discovery are leading opportunities for market.
Request For Sample Report- https://kenresearch.com/sample-report.php?Frmdetails=NDQ0NTQz
Based on geographic analysis, the North-America is a prevalent region in global electrophoresis reagents market owing to increase in drug discovery projects, stringent regulatory requirements for the pharmaceutical sector and increase in number of proteomic & genomic research projects across the region. The Asia-Pacific and Europe regions are anticipated to exhibit higher growth rate due to rise in health awareness coupled with growth in adoption of advanced technology over the forecast period. It is estimated that future of the global electrophoresis reagents market will be optimistic on account of increase in application of capillary electrophoresis in microbial detection during the forecast period.
For More Information, refer to below link:-
Ankur Gupta, Head Marketing & Communications